Christine N. Evans

480 total citations
13 papers, 201 citations indexed

About

Christine N. Evans is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Christine N. Evans has authored 13 papers receiving a total of 201 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 4 papers in Oncology and 3 papers in Immunology. Recurrent topics in Christine N. Evans's work include CRISPR and Genetic Engineering (4 papers), RNA and protein synthesis mechanisms (3 papers) and DNA Repair Mechanisms (2 papers). Christine N. Evans is often cited by papers focused on CRISPR and Genetic Engineering (4 papers), RNA and protein synthesis mechanisms (3 papers) and DNA Repair Mechanisms (2 papers). Christine N. Evans collaborates with scholars based in United States and Germany. Christine N. Evans's co-authors include Raj Chari, B. Zbar, Donald L. Granger, H. J. Rapp, E. Ribi, Michael T. Kelly, Mark Raffeld, Manjistha Sengupta, Armando Filie and Hye‐Jung Chung and has published in prestigious journals such as Nucleic Acids Research, Journal of Biological Chemistry and Molecular and Cellular Biology.

In The Last Decade

Christine N. Evans

13 papers receiving 194 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Christine N. Evans United States 8 97 73 56 34 23 13 201
Di He China 6 138 1.4× 73 1.0× 61 1.1× 62 1.8× 9 0.4× 7 233
Devora Delman United States 6 91 0.9× 72 1.0× 44 0.8× 16 0.5× 9 0.4× 8 188
Jun Zou China 6 72 0.7× 45 0.6× 18 0.3× 35 1.0× 10 0.4× 12 145
Oleksandr Kyrysyuk United States 6 60 0.6× 139 1.9× 173 3.1× 25 0.7× 12 0.5× 7 249
Boning Zhang United States 7 152 1.6× 77 1.1× 68 1.2× 37 1.1× 6 0.3× 18 250
Jamie Z. Roberts United Kingdom 5 184 1.9× 60 0.8× 61 1.1× 24 0.7× 10 0.4× 8 247
Varun Sahu United States 8 98 1.0× 72 1.0× 16 0.3× 18 0.5× 15 0.7× 10 179
Venkatesh Kancherla Switzerland 6 72 0.7× 101 1.4× 30 0.5× 24 0.7× 9 0.4× 8 188
Yifan Sun China 6 101 1.0× 42 0.6× 59 1.1× 15 0.4× 9 0.4× 8 173

Countries citing papers authored by Christine N. Evans

Since Specialization
Citations

This map shows the geographic impact of Christine N. Evans's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christine N. Evans with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christine N. Evans more than expected).

Fields of papers citing papers by Christine N. Evans

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christine N. Evans. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christine N. Evans. The network helps show where Christine N. Evans may publish in the future.

Co-authorship network of co-authors of Christine N. Evans

This figure shows the co-authorship network connecting the top 25 collaborators of Christine N. Evans. A scholar is included among the top collaborators of Christine N. Evans based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christine N. Evans. Christine N. Evans is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Yang, Liping, Guojun Yu, Pradip Bajgain, et al.. (2024). Uncovering receptor-ligand interactions using a high-avidity CRISPR activation screening platform. Science Advances. 10(7). eadj2445–eadj2445. 1 indexed citations
2.
Sahu, Sounak, Teresa Sullivan, Alexander Y. Mitrophanov, et al.. (2023). Saturation genome editing of 11 codons and exon 13 of BRCA2 coupled with chemotherapeutic drug response accurately determines pathogenicity of variants. PLoS Genetics. 19(9). e1010940–e1010940. 8 indexed citations
3.
Kim, Yong, Robert G. Hawley, Teresa S. Hawley, et al.. (2023). Abstract 3538: Endogenous HiBiT-tagging of PAX3-FOXO1 identifies potent suppressors of PAX3-FOXO1 protein levels by high-throughput screening. Cancer Research. 83(7_Supplement). 3538–3538. 1 indexed citations
4.
Evans, Christine N., et al.. (2023). An engineered cell line with a hRpn1-attached handle to isolate proteasomes. Journal of Biological Chemistry. 299(8). 104948–104948. 2 indexed citations
5.
Gamage, Supuni Thalalla, Robert Kopajtich, Christine N. Evans, et al.. (2022). Protonation-Dependent Sequencing of 5-Formylcytidine in RNA. Biochemistry. 61(7). 535–544. 11 indexed citations
6.
Ruf, Benjamin, Simon Wabitsch, Chi Ma, et al.. (2021). Activating Mucosal-Associated Invariant T Cells Induces a Broad Antitumor Response. Cancer Immunology Research. 9(9). 1024–1034. 39 indexed citations
7.
Tewary, Poonam, Alan D. Brooks, Ya-Ming Xu, et al.. (2021). Small-Molecule Natural Product Physachenolide C Potentiates Immunotherapy Efficacy by Targeting BET Proteins. Cancer Research. 81(12). 3374–3386. 12 indexed citations
8.
Evans, Christine N., et al.. (2020). dbGuide: a database of functionally validated guide RNAs for genome editing in human and mouse cells. Nucleic Acids Research. 49(D1). D871–D876. 20 indexed citations
9.
Tandon, Mayank, Christine N. Evans, Kimberly D. Klarmann, et al.. (2020). Impact of Losing hRpn13 Pru or UCHL5 on Proteasome Clearance of Ubiquitinated Proteins and RA190 Cytotoxicity. Molecular and Cellular Biology. 40(18). 19 indexed citations
10.
Khanal, Manakamana, Junko Murai, Jingli Zhang, et al.. (2020). Sensitivity of Mesothelioma Cells to PARP Inhibitors Is Not Dependent on BAP1 but Is Enhanced by Temozolomide in Cells With High-Schlafen 11 and Low-O6-methylguanine-DNA Methyltransferase Expression. Journal of Thoracic Oncology. 15(5). 843–859. 54 indexed citations
11.
Khanal, Manakamana, Junko Murai, Qun Jiang, et al.. (2019). MA12.03 PARP Inhibitor Sensitivity Does Not Depend on BAP1 but Is Enhanced by Temozolomide in MGMT Deficient Human Mesothelioma Cells. Journal of Thoracic Oncology. 14(10). S296–S296. 1 indexed citations
12.
Evans, Christine N.. (1977). Can synthetic cutting fluids cause cancer?. Tribology International. 10(1). 47–48. 2 indexed citations
13.
Zbar, B., E. Ribi, Michael T. Kelly, et al.. (1976). Immunologic approaches to the treatment of human cancer based on a guinea pig model. Cancer Immunology Immunotherapy. 1(3). 127–137. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Di He Breakdown of academic impact, for papers by Devora Delman Breakdown of academic impact, for papers by Jun Zou Breakdown of academic impact, for papers by Oleksandr Kyrysyuk Breakdown of academic impact, for papers by Boning Zhang Breakdown of academic impact, for papers by Jamie Z. Roberts Breakdown of academic impact, for papers by Varun Sahu Breakdown of academic impact, for papers by Venkatesh Kancherla Breakdown of academic impact, for papers by Yifan Sun
Rankless by CCL
2026